NeoImmuneTech, Inc. (KOSDAQ: 950220)

NeoImmuneTech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	52,402	68,739	115,630	154,250	71,217	102,149
Short-Term Investments	2,095	333.38	1,445	220.29	0.9	5,890
Cash & Short-Term Investments	54,497	69,072	117,075	154,471	71,218	108,039
Cash Growth	-40.25%	-41.00%	-24.21%	116.90%	-34.08%	130.50%
Prepaid Expenses	-	3,185	895.8	-	-	-
Other Current Assets	5,157	-	-0	12,252	9,414	1,654
Total Current Assets	59,654	72,257	117,971	166,722	80,632	109,692
Property, Plant & Equipment	5,622	7,749	9,397	9,056	4,058	3,082
Other Intangible Assets	6,376	6,168	6,554	6,591	6,471	7,335
Other Long-Term Assets	967.94	4,338	5,944	4,659	4,484	1,159
Total Assets	72,620	90,511	139,865	187,027	95,645	121,268
Accrued Expenses	9,522	8,764	12,945	17,426	7,493	1,319
Current Portion of Leases	1,062	1,353	1,279	1,284	545.01	441.48
Current Income Taxes Payable	-	58.51	92.49	59.33	21.63	-
Other Current Liabilities	1,660	2,710	2,080	1,642	938.61	1,247
Total Current Liabilities	12,244	12,886	16,397	20,411	8,998	3,007
Long-Term Leases	1,385	2,555	3,572	4,511	2,360	2,375
Other Long-Term Liabilities	63.46	62.24	64.34	63.09	0	0
Total Liabilities	13,795	15,655	20,176	24,985	11,418	5,382
Common Stock	2.75	2.55	2.51	2.34	1.8	1.91
Additional Paid-In Capital	318,664	295,772	290,644	271,282	142,448	151,159
Retained Earnings	-287,907	-246,517	-190,424	-122,781	-62,771	-36,913
Comprensive Income & Other	28,066	25,599	19,466	13,539	4,547	1,638
Shareholders' Equity	58,825	74,856	119,689	162,042	84,227	115,886
Total Liabilities & Equity	72,620	90,511	139,865	187,027	95,645	121,268
Total Debt	2,447	3,908	4,851	5,795	2,905	2,816
Net Cash (Debt)	52,050	65,164	112,224	148,676	68,312	105,223
Net Cash Growth	-40.00%	-41.93%	-24.52%	117.64%	-35.08%	124.49%
Net Cash Per Share	526.89	659.23	1136.26	1560.75	826.59	1292.31
Filing Date Shares Outstanding	100.26	494.34	494.14	492.91	413.63	411.63
Total Common Shares Outstanding	100.26	494.34	494.14	492.91	413.63	411.63
Working Capital	47,410	59,371	101,574	146,311	71,633	106,685
Book Value Per Share	586.74	151.43	242.22	328.75	203.63	281.53
Tangible Book Value	52,449	68,689	113,136	155,452	77,756	108,551
Tangible Book Value Per Share	523.15	138.95	228.96	315.38	187.99	263.71
Machinery	6,206	5,727	4,864	3,027	1,307	432.53
Construction In Progress	-	-	-	764.66	46.55	-

Source: S&P Capital IQ. Standard template. Financial Sources.